{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-282988","form_type":"8-K","ticker":"HRTX","cik":"0000818033","company_name":"HERON THERAPEUTICS, INC. /DE/","filed_at":"2026-06-25T21:00:14+00:00","discovered_at":"2026-06-25T21:02:00.245775+00:00","generated_at":"2026-06-25T21:03:21.314549+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Heron Therapeutics receives Nasdaq notice for bid price below $1.00; 180 days to cure","bullets":["On June 25, 2026, Nasdaq notified Heron that its common stock closing bid price was below $1.00 for 30 consecutive trading days (May 12–June 24, 2026).","Company has 180 calendar days, until December 22, 2026, to regain compliance by maintaining bid price ≥ $1.00 for at least 10 consecutive days.","If not cured, Heron may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.","There is no immediate impact on trading; shares continue to trade under HRTX on Nasdaq Capital Market.","Company intends to monitor share price and explore options to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-282988","json":"https://secwatch.observer/filing/0001193125-26-282988.json","markdown":"https://secwatch.observer/filing/0001193125-26-282988.md","text":"https://secwatch.observer/filing/0001193125-26-282988.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818033/000119312526282988/0001193125-26-282988-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818033/000119312526282988/hrtx-20260625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:03:21.314549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}